CrystecPharma’s Kate Fawthorpe (Bristow) and Qun Shao recently attended the event Integrated Formulation Development: Solubility Enhancement, Modified Release and AI-Informed Drug Development at the Milton Park Innovation Centre in Oxfordshire, hosted by Quotient Sciences.
The event brought together pharmaceutical development professionals to discuss current challenges and innovations in formulation science, including strategies for overcoming poor drug solubility, designing modified-release systems and applying artificial intelligence to support formulation development.
Among the key takeaways were the benefits of adopting flexible development approaches to maximise the use of limited drug substance while helping to reduce development timelines. Attendees also gained insight into Quotient Sciences’ innovative use of AI-driven tools to support formulation design and minimise the number of experimental studies required during development.